Section 35-7-1801 – Short Title.
35-7-1801. Short title. This article is known and may be cited as the “Right To Try Act.”
Section 35-7-1802 – Definitions.
35-7-1802. Definitions. (a) As used in this article: (i) “Eligible patient” means a person who has: (A) A terminal illness; (B) Considered all other treatment options currently approved by the United States food and drug administration; (C) Received a recommendation from a physician for an investigational drug, biological product or device; (D) Given written, informed […]
Section 35-7-1803 – Availability of Investigational Drugs, Biological Products or Devices; Insurance Coverage.
35-7-1803. Availability of investigational drugs, biological products or devices; insurance coverage. (a) A manufacturer of an investigational drug, biological product or device may make the drug, product or device available to eligible patients in accordance with the provisions of this section. Nothing in this section shall be construed to require a manufacturer to make available […]
Section 35-7-1804 – Action Against Physician License Prohibited.
35-7-1804. Action against physician license prohibited. Notwithstanding any other provision of law, the Wyoming state board of medicine shall not revoke, fail to renew, suspend or take any other action against a physician’s license issued pursuant to W.S. 33-26-101 et seq., based solely on the physician’s recommendations to an eligible patient regarding access to or […]
Section 35-7-1805 – Access to Investigational Drugs, Biological Products and Devices.
35-7-1805. Access to investigational drugs, biological products and devices. An official, employee or agent of this state shall not block or attempt to block an eligible patient’s access to an investigational drug, biological product or device. Counseling, advice or a recommendation consistent with medical standards of care from a licensed health care provider is not […]
Section 35-7-1806 – No Cause of Action Created.
35-7-1806. No cause of action created. This article does not create a private cause of action against a manufacturer of an investigational drug, biological product or device, or against any other person or entity involved in the care of an eligible patient using the investigational drug, biological product or device, so long as the manufacturer […]